# Filing Detail

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001520138-20-000106
Filing Date
2020-03-11
Accepted
2020-03-11 17:13:27
Documents
62

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM S-1 AMENDMENT NO. 9 | bivi-20200311_s1a9.htm | S-1/A | 1116820
2 | EXHIBIT 1.1 | bivi-20200311_s1a9ex1z1.htm | EX-1.1 | 380545
3 | EXHIBIT 23.1 | bivi-20200311_s1a9ex23z1.htm | EX-23.1 | 2193
4 | EXHIBIT 23.3 | bivi-20200311_s1a9ex23z3.htm | EX-23.3 | 2729
5 | GRAPHIC | image_001.jpg | GRAPHIC | 1856
6 | GRAPHIC | image_002.jpg | GRAPHIC | 28096
7 | GRAPHIC | image_003.jpg | GRAPHIC | 2179
8 | GRAPHIC | image_004.jpg | GRAPHIC | 13609
9 | GRAPHIC | image_010.jpg | GRAPHIC | 4680
10 | GRAPHIC | image_013.jpg | GRAPHIC | 26956
11 | GRAPHIC | image_014.jpg | GRAPHIC | 27383
12 | GRAPHIC | image_019.jpg | GRAPHIC | 53598
13 | GRAPHIC | image_025.jpg | GRAPHIC | 27181
| Complete submission text file | 0001520138-20-000106.txt |  | 4309433

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
14 | XBRL DEFINITION FILE | bivi-20191231_def.xml | EX-101.DEF | 96035
15 | XBRL LABEL FILE | bivi-20191231_lab.xml | EX-101.LAB | 264700
16 | XBRL PRESENTATION FILE | bivi-20191231_pre.xml | EX-101.PRE | 202052
17 | XBRL INSTANCE FILE | bivi-20191231.xml | EX-101.INS | 612726
18 | XBRL SCHEMA FILE | bivi-20191231.xsd | EX-101.SCH | 32428
19 | XBRL CALCULATION FILE | bivi-20191231_cal.xml | EX-101.CAL | 40900

Mailing Address 2120 COLORADO AVE. SUITE 230 LOS ANGELES CA 90404
Business Address 2120 COLORADO AVE. SUITE 230 LOS ANGELES CA 90404 310-444-4300
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

EIN.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: S-1/A | Act: 33 | File No.: 333-231136 | Film No.: 20706158
SIC: 2834 Pharmaceutical Preparations